Schedule 13D ownership disclosure
TETRALOGIC PHARMACEUTICALS COR
Security class unavailable · CUSIP: 88165U109
Event date: 2016-11-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 0
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-156959
- Form type
- SC 13D
- Filer
- Hudson Bay Capital Management LP
- CIK
- CIK 1393825
- Filed
- Nov 14, 2016
- Reporting period
- Nov 02, 2016
- Description
- Schedule 13D beneficial ownership